NO180234C - Immunogent konjugat for behandling av septisk sjokk, forbindelser samt kovalent konjugat mellom D-glukosamin-disakkarid og et bærerprotein - Google Patents
Immunogent konjugat for behandling av septisk sjokk, forbindelser samt kovalent konjugat mellom D-glukosamin-disakkarid og et bærerproteinInfo
- Publication number
- NO180234C NO180234C NO931655A NO931655A NO180234C NO 180234 C NO180234 C NO 180234C NO 931655 A NO931655 A NO 931655A NO 931655 A NO931655 A NO 931655A NO 180234 C NO180234 C NO 180234C
- Authority
- NO
- Norway
- Prior art keywords
- conjugate
- septic shock
- compounds
- treatment
- carrier protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
- C07H11/04—Phosphates; Phosphites; Polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87940392A | 1992-05-07 | 1992-05-07 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO931655D0 NO931655D0 (no) | 1993-05-06 |
NO931655L NO931655L (no) | 1993-11-08 |
NO180234B NO180234B (no) | 1996-12-02 |
NO180234C true NO180234C (no) | 1997-03-12 |
Family
ID=25374087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO931655A NO180234C (no) | 1992-05-07 | 1993-05-06 | Immunogent konjugat for behandling av septisk sjokk, forbindelser samt kovalent konjugat mellom D-glukosamin-disakkarid og et bærerprotein |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0570682B1 (de) |
JP (1) | JPH0641200A (de) |
KR (1) | KR930023369A (de) |
AT (1) | ATE155790T1 (de) |
AU (1) | AU664609B2 (de) |
CA (1) | CA2095588A1 (de) |
DE (1) | DE69312391T2 (de) |
DK (1) | DK0570682T3 (de) |
ES (1) | ES2104984T3 (de) |
FI (1) | FI932053A (de) |
GR (1) | GR3024706T3 (de) |
IL (1) | IL105605A0 (de) |
NO (1) | NO180234C (de) |
SG (1) | SG47582A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008214256A (ja) * | 2007-03-02 | 2008-09-18 | Yaizu Suisankagaku Industry Co Ltd | 双頭型配糖化合物の製造方法及び双頭型配糖化合物並びに該双頭型配糖化合物を含有する糖鎖認識タンパク質結合剤 |
EP2326671A4 (de) * | 2008-09-05 | 2012-10-03 | Ca Nat Research Council | Auf lps basierende impfstoffe |
EP3436467A4 (de) * | 2016-03-30 | 2020-03-18 | Ayuvis Research, Inc. | Neuartige zusammensetzungen und therapeutische verfahren |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1187753B (it) * | 1985-07-05 | 1987-12-23 | Sclavo Spa | Coniugati glicoproteici ad attivita' immunogenica trivalente |
EP0484403A4 (en) * | 1989-07-27 | 1993-03-17 | Univax Biologics Incorporated | Lipid a analog/immunogenic carrier conjugates and the use thereof as vaccines |
-
1993
- 1993-03-17 DE DE69312391T patent/DE69312391T2/de not_active Expired - Fee Related
- 1993-03-17 EP EP93104369A patent/EP0570682B1/de not_active Expired - Lifetime
- 1993-03-17 ES ES93104369T patent/ES2104984T3/es not_active Expired - Lifetime
- 1993-03-17 DK DK93104369.9T patent/DK0570682T3/da active
- 1993-03-17 AT AT93104369T patent/ATE155790T1/de active
- 1993-03-17 SG SG1996002942A patent/SG47582A1/en unknown
- 1993-05-04 IL IL105605A patent/IL105605A0/xx unknown
- 1993-05-05 CA CA002095588A patent/CA2095588A1/en not_active Abandoned
- 1993-05-06 FI FI932053A patent/FI932053A/fi not_active Application Discontinuation
- 1993-05-06 JP JP5129939A patent/JPH0641200A/ja active Pending
- 1993-05-06 KR KR1019930007776A patent/KR930023369A/ko not_active Application Discontinuation
- 1993-05-06 AU AU38419/93A patent/AU664609B2/en not_active Ceased
- 1993-05-06 NO NO931655A patent/NO180234C/no unknown
-
1997
- 1997-09-11 GR GR970402350T patent/GR3024706T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO931655D0 (no) | 1993-05-06 |
SG47582A1 (en) | 1998-04-17 |
EP0570682A1 (de) | 1993-11-24 |
DE69312391D1 (de) | 1997-08-28 |
DK0570682T3 (da) | 1998-02-16 |
AU664609B2 (en) | 1995-11-23 |
DE69312391T2 (de) | 1997-12-11 |
JPH0641200A (ja) | 1994-02-15 |
EP0570682B1 (de) | 1997-07-23 |
FI932053A0 (fi) | 1993-05-06 |
CA2095588A1 (en) | 1993-11-08 |
AU3841993A (en) | 1993-11-11 |
KR930023369A (ko) | 1993-12-18 |
FI932053A (fi) | 1993-11-08 |
ES2104984T3 (es) | 1997-10-16 |
ATE155790T1 (de) | 1997-08-15 |
NO180234B (no) | 1996-12-02 |
NO931655L (no) | 1993-11-08 |
GR3024706T3 (en) | 1997-12-31 |
IL105605A0 (en) | 1993-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL104696A0 (en) | Dual carrier immunogenic construct and a vaccine containing the same | |
PL291855A1 (en) | Method of obtaining covalent conjugate of oligosaccharide with proteinous support | |
AU3065489A (en) | T-cell epitope as carriers molecule for conjugate vaccines | |
OA09776A (en) | "Improved vaccine compositions". | |
NZ223009A (en) | Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens | |
CA2145397A1 (en) | Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines | |
NZ309713A (en) | Oligosaccharides of S pneumoniae serotype 8 and their use in a vaccine | |
EP0220387A3 (en) | Conjugate vaccines against infections by gramnegative bacteria, methods for their preparation and their use | |
HU9401511D0 (en) | Vaccine against streptococcus suls infection | |
NO180234C (no) | Immunogent konjugat for behandling av septisk sjokk, forbindelser samt kovalent konjugat mellom D-glukosamin-disakkarid og et bærerprotein | |
DK101196A (da) | Histaminderivat, histamin-immunogen-konjugat samt antistof fremstillet mod konjugatet | |
AU6435596A (en) | Pasteurella haemolytica type A-1 bacterin-toxoid vaccine | |
EP0512023A4 (en) | Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens | |
ATE87926T1 (de) | Ethylierte avermectine. | |
SE8703453D0 (sv) | Preparation innehallande hogmolekylert bakteriellt protein, antikroppspreparation riktad deremot samt preparationernas anvendning | |
NZ337730A (en) | use of an oligosaccharide hapten- carrier conjugate for immunizing against a bacterial or viral pathogen by administering | |
DK49685A (da) | Fremgangsmaade til fremstilling af en modificeret levende pasteurella haemolytica vaccine | |
IT1248485B (it) | Derivati della 1,4-benzotiazina ad azione immunostimolante e immonomodulatrice |